Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-31

Clinical Trial Update: Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS) [NA]

View source ↗

Summary

A completed clinical trial evaluating adrenocorticotropic hormone stimulation in Postural Orthostatic Tachycardia Syndrome (POTS) with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • adrenocorticotropic hormone stimulation

Snippet

Sponsor: Vanderbilt University | Conditions: Postural Tachycardia Syndrome | NA | Status: COMPLETED | Results posted: 2022-03-31